ArticleAlzheimer's research & therapy2026
BIN1 gain-of-function in the presynaptic compartment leads to isoform-specific synaptotoxicity.
Article in Alzheimer's research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
backgroundAlzheimer's disease (AD) is associated with strong genetic predisposition and early synaptic loss that correlates with cognitive decline. While genetic determinants are thought to contribute to synaptic vulnerability, their precise role in AD pathogenesis at the synaptic level remains unclear. BIN1, a major AD susceptibility gene, is expressed in multiple isoforms, but isoform-specific effects at synapses have not been well defined.
methodsWe investigated the impact of human BIN1 isoforms on synaptic structure and function using Drosophila and mammalian models. In flies, we overexpressed human BIN1 isoforms in retinal photoreceptor neurons and motoneurons, assessing synaptic function by electrophysiology and ultrastructural analyses. Morphological changes at neuromuscular junctions were also quantified. For both readouts, Rab11 modulation was tested as a potential rescue strategy. To determine conservation in mammals and distinguish presynaptic versus postsynaptic roles, we overexpressed BIN1 isoform 1 selectively in presynaptic or postsynaptic compartments of rat hippocampal neurons cultured in microfluidic devices. We assessed structural and functional connectivity using immunofluorescence and microelectrode arrays.
resultsGain-of-function of BIN1 isoform 1, but not isoforms 8 or 9, induced early loss of synaptic transmission in Drosophila photoreceptor neurons indicating BIN1iso1 synaptotoxicity. Structural analyses revealed accumulation of abnormally large vesicles in photoreceptor terminals, resembling BIN1-induced endosomal defects in cell bodies. Moreover, Rab11 gain-of-function prevented BIN1iso1 synaptotoxicity, suggesting that it originates from endosomal trafficking defects. In motoneurons, BIN1iso1 overexpression induced synapse remodelling, altering bouton morphology, including increased bouton number, reduced bouton size, and formation of satellite boutons. Rab11 modulation was additive to BIN1 isoform 1 effects, suggesting a distinct mechanism. In rat hippocampal neurons, BIN1 isoform 1 decreased synaptic connectivity only when overexpressed presynaptically, a finding confirmed by microelectrode array recordings.
conclusionsOur findings demonstrate that BIN1iso1 exerts isoform-specific, presynaptic disruption during synapse development and maintenance that compromises synaptic integrity across species. BIN1iso1 synaptotoxicity may contribute to early synapse loss observed in AD and provides mechanistic evidence that genetic determinants such as BIN1 predispose synapses to failure. These results highlight BIN1iso1 as a potential target for therapeutic strategies aimed at preserving synaptic function in AD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.